Skip to main content
    P

    Prothena Corporation plc (PRTA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $8.26
    +0.29 (+3.64%)

    Market Cap: $409.26M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Prothena Corporation plc (PRTA) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Prothena Corporation (PRTA) has a market cap of $409.26M and an enterprise value of $137.89M. Revenue grew 347.44% over the last 12 months from the 12 months before. It holds $271.37M more cash than debt, 66.31% of its market cap.

    Total Valuation

    Enterprise value is 66.31% below the market cap, as cash exceeds debt.

    Market Cap$409.26M
    Enterprise Value$137.89M
    Latest price (Nov 17, 2026)$8.26

    Key Dates

    The next earnings report is expected on Feb 17, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 17, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 1.36% in the quarter ended Sep 30, 2026 and shrank 2.21% a year over 2 years.

    Shares Outstanding51.44M
    Shares Change (YoY)-4.45%
    Shares Change (QoQ)-1.36%
    Share Count Growth (2Y CAGR)-2.21%

    Valuation Ratios

    Sales and book value multiples are 8.1x and 1.6x. Its year-end P/S ranged from 5.5x to 775.6x from 2017 to 2025.

    Forward P/E73.6x
    P/S Ratio8.1x
    Forward P/S5.4x
    P/B Ratio1.6x

    Valuation history and multiples

    Price Statistics

    The stock is down 16.82% over 52 weeks and trades 2.59% below its 50-day average.

    Beta (1Y)1.06
    52-Week Change-16.82%
    1-Month Change-2.59%
    3-Month Change-11.09%
    6-Month Change-8.93%
    5-Year Change-84.70%
    10-Year Change-82.29%
    Total Return (1Y)-16.82%
    Total Return (3Y CAGR)-37.63%
    Total Return (5Y CAGR)-31.47%
    Return vs SPY (1Y)-31.83%
    Max Drawdown (1Y)-31.45%
    Max Drawdown (3Y)-88.74%
    Sharpe Ratio (1Y)-0.47
    Correlation with SPY (1Y)0.30
    50-Day Average$8.48
    200-Day Average$9.17
    52-Week Range$7.73 to $11.80
    RSI (14 Days)47.9
    Average Volume (20 Days)452.73K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 23.95x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio23.95x
    Quick Ratio23.95x
    Debt / Equity0.00x
    Interest Coverage3.41x

    Returns and Efficiency

    Return on equity is -8.91% over the last 12 months, against a 5-year average of -28.55%.

    Return on Equity (ROE)-8.91%
    Return on Assets (ROA)-8.45%
    ROE (5Y Average)-28.55%
    ROA (5Y Average)-24.52%
    ROIC (5Y Average)-76.64%
    Asset Turnover0.17x

    Scores

    PRTA has an Altman Z-Score of 11.60, in the safe zone above 2.99, and a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Altman Z-Score11.60
    Altman Z ZoneSafe
    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $52.73M over the last 12 months.

    Revenue$52.73M
    Revenue Growth (YoY)+347.44%
    Gross Profit$52.73M
    Operating Income-$34.09M
    Pretax Income-$23.95M
    Net Income-$23.96M
    Reported EPS (TTM)-$0.42

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 94.82% of the $283.52M in total assets.

    Cash and Equivalents$271.37M
    Total Debt$0
    Net Cash$271.37M
    Net Cash Per Share$5.28
    Working Capital$262.43M
    Shareholder Equity$268.84M
    Book Value Per Share$5.23
    Total Assets$283.52M
    Total Liabilities$14.68M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $727.04K of capital spending, operating cash flow left -$32.17M of free cash flow.

    Operating Cash Flow-$31.45M
    Capital Expenditures$727.04K
    Free Cash Flow-$32.17M
    FCF Per Share-$0.63
    Depreciation and Amortization$1.53M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -64.64%.

    Gross Margin100.00%
    Operating Margin-64.64%
    Pretax Margin-45.41%
    Net Margin-45.43%
    FCF Margin-61.01%

    Growth

    Revenue fell 43.57% a year over 3 years.

    Revenue Growth (3Y CAGR)-43.57%
    Revenue Growth (5Y CAGR)+62.56%
    Book Value Per Share Growth (2Y CAGR)-29.42%
    Tangible Book Per Share Growth (2Y CAGR)-29.42%

    Revenue and profit by year

    Dividends and Yields

    PRTA does not pay a dividend. Its free cash flow yield is -7.57%.

    FCF Yield-7.57%
    Buyback Yield6.29%
    Shareholder Yield6.29%

    Peer Position

    Against 8 similar companies, PRTA has the 2nd highest P/S.

    P/S Ratio8.1x vs 3.9x median
    Revenue Growth (Trailing 4 Quarters, YoY)+347.44% vs +13.48% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at -9.82% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)-9.82%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About PRTA

    What is PRTA's market cap?

    Prothena Corporation has a market cap of $409.26M. Its enterprise value, which adds debt and subtracts cash, is $137.89M.

    How many shares of PRTA are outstanding?

    Prothena Corporation has 51.44M shares outstanding. The count is down 4.45% from a year earlier.

    Does PRTA pay a dividend?

    No. Prothena Corporation does not pay a dividend.

    How much debt does PRTA have?

    Prothena Corporation has $0 of total debt and $271.37M of cash and equivalents, a net cash position of $271.37M.